Skip to content

License Reinstated for Canadian Pharmacist Who Sold Counterfeit Cancer Drugs to the US

Canadian internet pharmacist Kristjan Thorkelson had his license reinstated by the College of Pharmacists of Manitoba only days after the regulatory authority suspended him, according to a report by CBC News. The sudden reversal reinforces LegitScript's assertion that Canadian regulation of these internet pharmacies is inadequate for protecting US consumers.

The Canadian regulatory authority confirmed to CBC News that the sanction was lifted in late December 2017 but offered no additional details. Thorkelson, who is the president of CanadaDrugs.com, had his license suspended less than a week previous because, according to the College's Complaint Committee, "his conduct presents or is likely to present a serious risk to the public."

Canadian rogue internet pharmacies such as CanadaDrugs use the defense that Canadian regulation is sufficient to protect consumers, both in the country where they operate and in other jurisdictions, such as the US. But the lightning speed with which Thorkelson's license was reinstated illustrates just how impotent these regulations are in safeguarding US consumers. Because CanadaDrugs didn't commit a violation of Canadian law and didn't harm Canadian citizens, regulatory authorities in that country have little cause or means to sanction the operator, even for crimes as egregious as selling counterfeit drugs.

In 2017, Thorkelson and five others were arrested last year and extradited to the United States for selling fake cancer drugs online. US federal prosecutors accused the men of illegally importing and selling $78 million worth of unapproved, misbranded, and counterfeit drugs to the US between 2009 and 2012.

Under a tentative plea agreement, which was detailed in US court documents filed in late December, Thorkelson would pay a $250,000 fine and serve six months of house arrest, followed by four and a half years of probation. The plea agreement would also have CanadaDrugs and two subsidiaries plead guilty, pay a $5 million fine, and forfeit $29 million. Were Thorkelson tried and convicted, he could face up to 20 years in prison.

According to CBC News, the presiding judge in a US district court in Montana must still accept the plea agreement. A date for that proceeding has been set for April 2018.

 

David Khalaf is a writing, communications, and marketing professional with specialties in media, investigations, content strategy, and writing instruction. His 20 years of writing, media, and communications work have included two top-tier universities (USC and UCLA), print and digital magazines, consulting firms, and technology companies.

His current work involves content strategy and development at LegitScript, a company that helps the world's leading search engines, payment service providers, and internet platforms and marketplaces do business with legitimate, legally operating entities in more than 80 countries and 15 languages around the world. LegitScript specializes in risk and compliance for highly regulated industries including CBD/cannabis, online gambling, cryptocurrencies, drugs, financial trading, online adult, scams and fraud, and more.

Recent Blog Articles

Merchant Onboarding Essentials: What You Need to Know

Modern merchant onboarding involves much more than collecting documents - it's about building a smart, scalable risk management process that can keep up with changing technology and fraud tactics. Whether you're launching a payments platform or refining your underwriting approach, getting onboarding...

LegitScript Marketplace Risk Panel Recap: The Dark Side of Weight-Loss Drugs: Regulation, Risk, and Red Flags

Marketplaces and other online platforms must constantly revisit and stress test their policies to ensure they are properly mitigating risk while providing sufficient room for growth. But what happens when a new regulation or trend upends those policies? Listen below to an excerpt of the panel discus...

Trust, Risk, and the Future of Compliance: Key Takeaways from Marketplace Risk San Francisco 2025

Marketplace Risk San Francisco 2025 offered a rare opportunity to pause the noise and listen closely to the industry, to its undercurrents, and to the questions no one's asking on stage. Once you're tuned in, you begin to hear the real story: an acute urgency around platform trust, growing anxieties...

Partnering for Compliance: What Platforms and Pharmaceutical Manufacturers Need to Know

Pharmaceutical manufacturing is a quickly growing sector that in recent years has been riding a wave of demand resulting from the booming telehealth industry, GLP-1 weight loss drugs, and an aging population requiring increasing medical care. Keep reading to understand how pharmaceutical manufacturi...